UROGEN’S FINAL RESULTS FROM OLYMPUS FIVE-YEAR FOLLOW-UP STUDY REINFORCES DURABLE RESPONSE WITH JELMYTO IN PATIENTS WITH LOW-GRADE UPPER TRACT UROTHELIAL CANCER

Reuters · 3d ago

Please log in to view news